Acme United Q2 sales rise on acquisitions, broad growth
ACU•Outlook
- Company expects My Medic business to generate most profitability in Q4
- Company anticipates high tariffs will continue to pressure margins, but at a decreasing rate
- Acme United aims for strengthening quarterly profitability through cost reductions and growth initiatives
Overview
- Safety solutions supplier's Q2 net sales rose 16% yr/yr, driven by broad-based growth
- Q2 net income increased 6% yr/yr; diluted EPS up 5%
- Gross margin improved to 42.6%, aided by My Medic acquisition
Key Details
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q2 Sales | Beat | $62.72 mln | $56.24 mln (2 Analysts) |
| Q2 Net Income | $5.05 mln | ||
| Q2 Basic EPS | $1.32 | ||
| Q2 Gross Profit | $26.69 mln | ||
| Q2 Operating Income | $6.83 mln | ||
| Q2 Pretax Profit | $6.30 mln |
Analyst coverage
- The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
